The Valley Desk

NCT02227147 · Interventional trial

Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK

Overall registry status Completed

Phase 2

Conditions Neurotrophic Keratitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov